Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Blood Cancer Journal|November 26, 2024
RSK1 dependency in FLT3-ITD acute myeloid leukemiaTim Kong, Angelo B A Laranjeira, Christopher T Letson, et al.
Blood Cancer Discovery|February 29, 2024
Spatial Mapping of Hematopoietic Clones in Human Bone MarrowAndrew L Young, Hannah C Davis, Maggie J Cox, et al.
Blood|April 21, 2010
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasmsStephen T Oh, Erin F Simonds, Carol Jones, et al.
Haematologica|November 20, 2025
JAK inhibitor selection in challenging scenarios of myelofibrosis: a reviewPankit Vachhani, Ruben Mesa, John Mascarenhas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritisJonathan J Miner, Han-Xian Aw-Yeang, Julie M Fox, et al.
Blood Advances|October 13, 2021
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibitionTim Kong, Angelo B A Laranjeira, Taylor B Collins, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
Nature Communications|March 24, 2023
IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass CytometryPeng Lu, Karolyn A Oetjen, Diane E Bender, et al.
Ejhaem|December 5, 2022
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosisNaveen Pemmaraju, Claire Harrison, Vikas Gupta, et al.
Cancer Research|October 24, 2018
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in LeukemiaDavid R Spiciarich, Stephen T Oh, Amy Foley, et al.
Pageof 10